Despite recent advances, the acute and long-term morbidity of current curative therapies can be substantial, and several childhood cancers still have unacceptably low cure rates. Does the development of molecularly targeted anticancer drugs offer the prospect of more effective therapy for childhood cancers?
- Robin E. Norris
- Peter C. Adamson
